Ruowei Mo

599 citations

14 papers · 335 indexed · h-index 10

Pharmacology top 5%
- Alkaloids: synthesis and pharmacology 2
Organic Chemistry top 10%
- Chemical synthesis and alkaloids 2
Oncology
- Chemokine receptors and signaling 8
- Cytokine Signaling Pathways and Interactions 2
Spectroscopy
Pharmacology
- Alkaloids: synthesis and pharmacology 2
Immunology
- Immune Cell Function and Interaction 6
- Mast cells and histamine 2
- Immunotherapy and Immune Responses 2
Molecular Biology
- Chemical Synthesis and Analysis 2

Co-authors: James McNulty Robert J. Cherney Carl P. Decicco Dayton T. Meyer Zelda R. Wasserman Delbert L. Herald Michael R. Boyd Romelo Gibe
Cited by: Pharmacology Organic Chemistry Oncology
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of Medicinal Chemistry (2 papers)ACS Medicinal Chemistry Letters (1 paper)
Partner nations: United States China Switzerland

In The Last Decade

Ruowei Mo

14 papers receiving 330 citations

Peers

Countries citing papers authored by Ruowei Mo

Since Specialization

Citations

This map shows the geographic impact of Ruowei Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruowei Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruowei Mo more than expected).

Fields of papers citing papers by Ruowei Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruowei Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruowei Mo. The network helps show where Ruowei Mo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ruowei Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ruowei Mo Line = papers co-authored together Ruowei Mo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Discovery of a brain-sparing GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillation Bioorganic & Medicinal Chemistry Letters ·Stefan Peukert,Akira FURUTA,Ruowei Mo,D. Scott Jackson,Fupeng Ma,Guillaume Barbe,Gregory R. Bebernitz,Cary Fridrich,Chiara Buono,Eric T. Williams,T.B. Daniels,Lisha Li,Marie‐Françoise Torchet,Yuichiro Adachi,Jishnu Andrabi Das,Andrew K.P. Taggart	2023	3
2	Merging Biocatalysis, Flow, and Surfactant Chemistry: Innovative Synthesis of an FXI (Factor XI) Inhibitor Organic Process Research & Development ·Bin Wu,Sisi Zhang,Tao Hong,Mehreen Sishar,Hui Wang,Min Shi,Hongwei Yang,Xiangguang Tian,Jing Guo,Jianwei Bian,张灿玾,C. Jeong,Ruowei Mo,Cary Fridrich,Feng Gao,Jianhua Wang	2020	14
3	Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5 ACS Medicinal Chemistry Letters ·Percy H. Carter,Shaimaa Hassan Abbas Al-Junaibi,Robert J. Cherney,Douglas G. Batt,Jing Chen,Tara Suntum,Mary Ellen Cvijic,John V. Duncia,Soo S. Ko,Sandhya Mandlekar,Ruowei Mo,David J. Nelson,Jian Pang,Anne Rose,Joseph B. Santella,Andrew J. Tebben,Sarah C. Traeger,KF Peters,Qihong Zhao,Joel C. Barrish	2015	11
4	Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,Ruowei Mo,Michael G. Yang,Zili Xiao,Qihong Zhao,Sandhya Mandlekar,Mary Ellen Cvijic,Israel Charo,Joel C. Barrish,Carl P. Decicco,Percy H. Carter	2014	1
5	Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,Ruowei Mo,Dayton T. Meyer,Jiangtao Dang,Edson Rodrigo Rosa Pereira,Sahoko Komatsu,Gengjie Yang,Mohammad Maanijoo,Peggy Scherle,Qihong Zhao,Mary Ellen Cvijic,Joel C. Barrish,Carl P. Decicco,Percy H. Carter	2012	4
6	Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2) Bioorganic & Medicinal Chemistry Letters ·Michael G. Yang,Zili Xiao,Qing Shi,Robert J. Cherney,Andrew J. Tebben,George V. De Lucca,Joseph B. Santella,Ruowei Mo,Mary Ellen Cvijic,Qihong Zhao,Joel C. Barrish,Percy H. Carter	2011	2
7	γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,Ruowei Mo,Dayton T. Meyer,Matthew E. Voss,Michael G. Yang,Joseph B. Santella,John V. Duncia,Sahoko Komatsu,Gengjie Yang,Mohammad Maanijoo,Peggy Scherle,Qihong Zhao,Sandhya Mandlekar,Mary Ellen Cvijic,Joel C. Barrish,Carl P. Decicco,Percy H. Carter	2010	15
8	Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,Ruowei Mo,Dayton T. Meyer,Matthew E. Voss,Sahoko Komatsu,Gengjie Yang,Mohammad Maanijoo,Peggy Scherle,Andrew J. Tebben,Percy H. Carter,Carl P. Decicco	2009	12
9	Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,Colette Aguerre,Ruowei Mo,Sahoko Komatsu,Gengjie Yang,Mohammad Maanijoo,Peggy Scherle,Bruce F. Molino,Percy H. Carter,Carl P. Decicco	2008	15
10	Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists Journal of Medicinal Chemistry ·Robert J. Cherney,Ruowei Mo,Dayton T. Meyer,David J. Nelson,Sahoko Komatsu,Gengjie Yang,Peggy Scherle,Sandhya Mandlekar,Zelda R. Wasserman,Chas. Cortlandt Walton,Kimberly A. Solomon,Andrew J. Tebben,Percy H. Carter,Carl P. Decicco	2008	39
11	Sultam Hydroxamates as Novel Matrix Metalloproteinase Inhibitors Journal of Medicinal Chemistry ·Robert J. Cherney,Ruowei Mo,Dayton T. Meyer,Karl D. Hardman,Rui‐Qin Liu,Maryanne Covington,Mingxin Qian,Zelda R. Wasserman,David D. Christ,James M. Trzăskos,Robert Newton,Carl P. Decicco	2004	80
12	Potent and selective aggrecanase inhibitors containing cyclic P1 substituents Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,Ruowei Mo,Dayton T. Meyer,Li Wang,Wenqing Yao,Zelda R. Wasserman,Rui‐Qin Liu,Maryanne Covington,Micky D. Tortorella,Elizabeth C. Arner,Mingxin Qian,David D. Christ,James M. Trzăskos,Robert Newton,R. L. Magolda,Carl P. Decicco	2003	27
13	Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore Bioorganic & Medicinal Chemistry Letters ·James McNulty,Christian Later,Romelo Gibe,Ruowei Mo,Lauren Dozier,George R. Pettit,Delbert L. Herald,Michael R. Boyd	2001	73
14	Diastereoselective intramolecular nitroaldol entry to lycoricidine alkaloids Chemical Communications ·James McNulty,Ruowei Mo	1998	39

About Ruowei Mo

Ruowei Mo is a scholar working on Oncology, Immunology, Pharmacology, Organic Chemistry and Environmental Chemistry, having authored 14 papers that have together received 335 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (8 papers), Immune Cell Function and Interaction (6 papers), Chemical Synthesis and Analysis (2 papers), Mast cells and histamine (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Immunotherapy and Immune Responses (2 papers), Alkaloids: synthesis and pharmacology (2 papers) and Chemical synthesis and alkaloids (2 papers). The work is most often cited by research in Pharmacology (84 citations), Organic Chemistry (210 citations), Oncology (85 citations), Spectroscopy (43 citations) and Pharmacology (42 citations). Ruowei Mo has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include James McNulty, Robert J. Cherney, Carl P. Decicco, Dayton T. Meyer, Zelda R. Wasserman, Delbert L. Herald, Michael R. Boyd, Romelo Gibe, George R. Pettit and James M. Trzăskos. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Chemical Communications and Organic Process Research & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact